Healthcare Services Group, Inc. (HCSG) vs Kailera Therapeutics, Inc. (KLRA)
A side-by-side comparison of Healthcare Services Group, Inc. and Kailera Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
HCSG
Healthcare Services Group, Inc.
$21.29HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
KLRA
Kailera Therapeutics, Inc.
$10.87HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
Total return — HCSG vs KLRA
growth of $100 · dividends reinvested · last 1yHCSG +10.4% (+10.4%/yr)KLRA -58.3% (-58.3%/yr)HCSG compounded faster over this window
HCSG KLRA
HCSG vs KLRA: by the numbers
- •HCSG is the larger company ($1.46B vs $1.41B market cap).
- •HCSG is profitable (6.59% net margin) while KLRA runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | HCSG | KLRA |
|---|---|---|
| P/E ratio | 12.45 | N/A |
| Forward P/E | 17.75 | N/A |
| P/S ratio | 0.78 | N/A |
| P/B ratio | 2.82 | 1.26 |
| EV / EBITDA | 9.01 | N/A |
| FCF yield | 10.37% | N/A |
Profitability
| Metric | HCSG | KLRA |
|---|---|---|
| Gross margin | 17.33% | 0.00% |
| Operating margin | 7.03% | 0.00% |
| Net margin | 6.59% | 0.00% |
| ROE | 23.70% | N/A |
| ROIC | 16.83% | -24.52% |
Growth (annualized)
| Metric | HCSG | KLRA |
|---|---|---|
| Revenue CAGR (5Y) | 2.29% | N/A |
| EPS CAGR (5Y) | -9.08% | N/A |
| FCF CAGR (5Y) | -8.15% | N/A |
| Total return CAGR (5Y) | -2.00% | N/A |
Frequently asked
- Is HCSG or KLRA more profitable?
- HCSG runs the higher net margin — HCSG at 6.59% versus KLRA at 0.00%.
Go deeper
Dig into the metrics
Healthcare Services P/E ratioHealthcare Services ROEKailera Therapeutics ROEHealthcare Services operating marginKailera Therapeutics operating marginHealthcare Services revenue growthKailera Therapeutics revenue growthHealthcare Services free cash flowKailera Therapeutics free cash flow
Healthcare Services & Kailera Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.